05:09 PM, 30th Jan 2026
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025.The Notice can be accessed at the Companys website at www.gkb.netFurther notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Inside Trading Window) Regulations 2015 had been closed from January 01 2026 will now re-open after the completion of 48 hours from the date of submission of Financial results to the Stock Exchange.This communication has been sent to all the Directors and all the designated employees of the Company.